Error message

  • Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in _menu_load_objects() (line 569 of /home/suturepl/public_html/dolphinsutures/includes/
  • Deprecated function: Methods with the same name as their class will not be constructors in a future version of PHP; views_display has a deprecated constructor in require_once() (line 3196 of /home/suturepl/public_html/dolphinsutures/includes/
  • Deprecated function: Methods with the same name as their class will not be constructors in a future version of PHP; views_many_to_one_helper has a deprecated constructor in require_once() (line 113 of /home/suturepl/public_html/dolphinsutures/sites/all/modules/ctools/ctools.module).
Polyglactin Sutures | Petcryl 910Polyglactin 910 suture

PETCRYL 910 - Polyglactin 910 Suture

Petcryl 910 is the brand name of Polyglactin 910 sutures made by Dolphin Sutures. Dolphin Sutures is the first Indian brand to introduce Polyglactin sutures in India. 


Polyglactin suture is a braided and coated synthetic absorbable suture and is a co-polymer of 90% Glycolide and 10% L-lactide. Polyglactin 910 sutures retain tensile strength of about 70% of initial strength at 14 days of implantation. Polyglactin 910 sutures are indicated for soft tissue approximation and ligation. Polyglactin sutures have mild tissue reaction during the absorption process. Polyglactin 910 sutures manufactured by Dolphin Sutures is similar in composition to Vicryl sutures and has a similar absorption profile.


Polyglactin suture is a much superior alternative to catgut sutures since its absorption is more predictable, tensile strength is better and it exhibits little or no tissue reaction. Polyglactin sutures also exhibit better knotting properties compared to PGA sutures.


Petcryl 910 sutures are available in undyed and violet colour from U.S.P. size 6-0 to size 2.


Also available:- Polyglactin rapid absorption sutures


   Instructions for Use


  • Polyglactin suture is a synthetic, braided and coated absorbable suture
  • Polyglactin sutures are available from U.S.P. size 2 to size 6-0 with needle and without needle as well
  • Polyglactin sutures are composed of copolymers made from 90% glycolide and 10% L-lactide
  • Polyglactin sutures are coated with equal parts of a copolymer of lactide and glactide with calcium stearate
  • Polyglactin sutures absorb by simple hydrolytic mechanism and absorption is predictable
  • Petcryl 910 suture retains 70% of the initial strength after 2 weeks of implantation
  • Petcryl 910 suture is specially coated with Poly (glycolide-Co-L-lactide) in order to create a smoother suture that will pass through tissue easily
  • Petcryl 910 sutures have good knot security and it has easy knot placement
  • Petcryl 910 sutures are available with needles made from 300 series alloy steel for superior strength, sharpness and performance


STERILE ABSORBABLE POLYGLACTIN 910 SURGICAL SUTURE U.S.P                                        


PETCRYL® 910 suture is a braided coated synthetic sterile Polyglactin 910 surgical suture. It is composed of a copolymer made from 90% Glycolide and 10% L - Lactide.

PETCRYL® 910 sutures are coated with a mixture containing equal parts of copolymer of glycolide and Lactide (Polyglactin 370) and Calcium Stearate.

Polyglactin 910 co-polymer and Polyglactin 370 with Calcium Stearate exhibit non-antigenic, non-pyrogenic and elicit only a slight tissue reaction during absorption.

PETCRYL® 910 sutures are dyed by adding D & C Violet No. 2 (Colour Index No. 60725) during polymerization. PETCRYL® 910 sutures are also available in undyed form.

PETCRYL® 910  sutures are available in range of gauge sizes and lengths, non needled or attached to stainless steel needles of varying types, sizes and shapes. The needles are attached permanently to the suture. Entire details of the product range are available in the catalogue.

PETCRYL® 910 complies with the “Absorbable Surgical Suture” requirements as per the United States Pharmacopoeia (U.S.P).


Petcryl® 910 suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic surgery, peripheral nerve anastomosis and microsurgery for vessels less than 2 mm diameter. The safety and effectiveness of PETCRYL® 910 sutures in cardiovascular tissue have not been established.



PETCRYL® 910 sutures should be selected and implanted depending on the patient’s condition, surgical experience, surgical technique and wound size.



PETCRYL® 910 suture leads to ingrowth of fibrous connective tissue due to minimal initial inflammatory tissue reaction. PETCRYL® 910 gradually loses tensile strength and is finally absorbed by hydrolytic process. During hydrolysis, the co-polymer degrades to glycolic and lactic acids which are then absorbed and metabolized in the body. Absorption begins as a loss of tensile strength followed by a loss of mass. Absorption pattern for suture when tested on rats:-

Approx 94.1 % of the tensile strength at 7 days,

Approx 74.9 % of tensile strength at 14 days,

Approx 49.1 % tensile strength after 21 days and

Approx 26.7 % tensile strength after 28 days.



Adverse reaction, associated with the use of the device include transitory local irritation at the wound site, transitory inflammatory foreign body response, erythema and induration during the absorption process of subcuticular sutures. Like all foreign bodies, PETCRYL ® 910 suture may enhance an existing infection.


Petcryl® 910 suture, being absorbable, should not be used where extended approximation of tissues under stress is required. The use of this suture is contraindicated in patients with known sensitivities or allergies to Polyglactin, polyglycolide co lactide, calcium stearate.



  1. Surgeons should be familiar with surgical procedures and techniques involving absorbable sutures before employing PETCRYL® 910 suture for wound closure, as the risk of wound dehiscence may vary with the site of application and the suture material used.
  2. In surgery of the urinary or biliary tract, care should be taken to avoid prolonged contact of this or any other suture with salt solution, to prevent calculus formation.
  3. This suture many be inappropriate in patients suffering from conditions which may delay wound healing e.g., patient that are elder, malnourished or depilated. As this is an absorbable suture, the use of supplemental non-absorbable suture should be considered by the surgeon in the close of the abdomen, chest, joints or other sites subjects to expansion or requiring additional support.
  4. For single use only. Do not reuse, reprocess or re-sterilize. Reuse, reprocessing or re‐sterilization may compromise the structural integrity of the device and/ or lead to device failure which, in turn, may result in patient injury or illness.
  5. Reuse, reprocessing or re‐sterilization may also create a risk of contamination of the device and/or cause patient infection or cross‐infection, including, but not limited to, the transmission of infectious disease(s) from one patient to another.
  6. Contamination of the device may lead to injury, or illness.



  1. Acceptable surgical practice should be followed for the management of contaminated or infected wounds.
  2. Skin sutures which must remain in place longer than 7 days may cause localized irritation and should be snipped off or removed as indicated.
  3. Under some circumstances, notably orthopaedic procedures, immobilization of joints by external support may be employed at the discretion of the surgeon.
  4. Consideration should be taken in the use of absorbable sutures in tissues with poor blood supply as suture extrusion and delayed absorption may occur.
  5. Subcuticular sutures should be placed as deeply as possible to minimize the erythema and induration, normally associated with the absorption process.
  6. When handling this or any other suture, care should be taken to avoid damage from handling. Avoid crushing or crimping damage due to application of surgical instruments such as forceps or needle holders.
  7. Care should be taken to avoid damage while handling surgical needles. Grasp the needle in an area, one third (1/3) to one half (1/2) of the distance from the attachment end to the point.
  8. Grasping in the point area could impair the penetration performance and cause fracture of the needle.
  9. Grasping at the butt or attachment end could cause bending or breakage.
  10. Reshaping the needles may cause them to loose strength and make less resistant to bending and breaking.
  11. Users should exercise caution when handling surgical needles to avoid inadvertent needle stick injury. Discard the needles after use.



PETCRYL® 910 sutures are sterilized by ethylene oxide. Do not re – sterilize! Do not use if package is opened or damaged! Discard opened unused sutures.



Recommended storage condition 10oC-35°C, away from moisture and direct heat. Do not use after expiry date.



Discard used sutures and needles contaminated with blood in the container meant infectious waste. Unused expired pouches should be incinerated.


  • Polyglactin sutures are individually packed in a primary medical grade paper folder
  • Individually packed sutures are then packed in a tear-open or peel-open aluminum foil, with less than 300ppm moisture
  • Aluminum foils are further packed in a secondary medical grade paper pouch laminated with polyester laminated poly film
  • Sutures are further packed in small cartons made from premium 320 GSM Cyber XLPac in 12 suture pack
  • Boxes are further laminated in tamper proof film to protect it from dirt/dust
  • Further, the sutures are packed in an export worthy 7 ply master carton which can accommodate 100 boxes ( 70 x 30 x 30 cms) - weighing up to 9 to 10kg and 200 boxes ( 70 x 29 x 59 cms) - weighing up to 18kg
, , ,